A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Clinical trial NCT04923347 · COMPLETED

Trial details

NCT number: NCT04923347
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2023-06-06
Primary completion: 2024-03-14
Enrollment: 229

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.